WEST PHARMACEUTICAL SERVICES, INC. — Operating Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/72e79d2c-d0e9-48bf-a0b3-bb63115bebe0/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $584.9M | 2025-01-01 – 2025-12-31 | evidence 0000105770-26-000010 |
| FY 2024 | $569.9M | 2024-01-01 – 2024-12-31 | evidence 0000105770-25-000013 |
| FY 2023 | $676.0M | 2023-01-01 – 2023-12-31 | evidence 0000105770-24-000015 |
| FY 2022 | $734.0M | 2022-01-01 – 2022-12-31 | evidence 0000105770-23-000012 |
| FY 2021 | $752.3M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-003342 |
| FY 2020 | $406.9M | 2020-01-01 – 2020-12-31 | evidence 0000105770-21-000008 |
| FY 2019 | $296.6M | 2019-01-01 – 2019-12-31 | evidence 0000105770-20-000015 |
| FY 2018 | $240.3M | 2018-01-01 – 2018-12-31 | evidence 0000105770-19-000012 |
| FY 2017 | $225.8M | 2017-01-01 – 2017-12-31 | evidence 0000105770-19-000012 |
| FY 2016 | $195.2M | 2016-01-01 – 2016-12-31 | evidence 0000105770-19-000012 |
| FY 2015 | $128.6M | 2015-01-01 – 2015-12-31 | evidence 0000105770-16-000060 |
| FY 2014 | $182.0M | 2014-01-01 – 2014-12-31 | evidence 0000105770-15-000007 |
| FY 2013 | $162.4M | 2013-01-01 – 2013-12-31 | evidence 0000105770-14-000005 |
| FY 2012 | $135.1M | 2012-01-01 – 2012-12-31 | evidence 0000105770-13-000007 |
| FY 2011 | $109.6M | 2011-01-01 – 2011-12-31 | evidence 0000105770-12-000013 |
| FY 2010 | $90.7M | 2010-01-01 – 2010-12-31 | evidence 0000105770-11-000016 |
| FY 2009 | $97.5M | 2009-01-01 – 2009-12-31 | evidence 0000105770-11-000016 |
| FY 2008 | $124.1M | 2008-01-01 – 2008-12-31 | evidence 0000105770-11-000016 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
WEST PHARMACEUTICAL SERVICES, INC. — all facts · Revenue · Net Income